SCHEMBL29447697

SCHEMBL29447697

CC(C(N)=O)=C(Cc1ccccc1)n1ccnn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 8/20 0.39
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
AKR1B1 P15121 1/20 0.35
OPRD1 P41143 1/20 0.35
OPRK1 P41145 1/20 0.35
HIF1A Q16665 1/20 0.34
NR1H2 P55055 1/20 0.34
NR1H3 Q13133 1/20 0.34
ELOVL1 Q9BW60 1/20 0.34
CACNA1G O43497 1/20 0.34
CACNA1I Q9P0X4 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
AURKA O14965 1/20 0.33
CCNA2 P20248 1/20 0.33
CDK2 P24941 1/20 0.33
CCNA1 P78396 1/20 0.33
EPHX2 P34913 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14833338 0.76 CYP19A1 (0.47) CYP19A1CES2CES1AKR1B1
SCHEMBL31476894 0.69 CES1 (0.50) CES2CES1AKR1B1HIF1AEPHX2
SCHEMBL2866676 0.69 CES1 (0.50) CES2CES1AKR1B1HIF1AEPHX2
SCHEMBL21816275 0.68 F2 (0.46) CYP19A1
SCHEMBL24937837 0.68 NPC1 (0.49)
SCHEMBL553681 0.66 CES1 (0.47) CES2CES1AKR1B1HIF1A
SCHEMBL553684 0.66 CES1 (0.47) CES2CES1AKR1B1HIF1A
SCHEMBL3171335 0.65 CES1 (0.54) CES2CES1AKR1B1HIF1AEPHX2
SCHEMBL8508057 0.65 P2RX4 (0.51) CYP1A2CYP2C9CYP2C19
SCHEMBL876240 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3946433-A1 COMPOSITIONS, DEVICES AND METHODS FOR TREATING FABRY DISEASE Sigilon Therapeutics, Inc. (US) 2022-02-09 EP disclosed